PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 106 filers reported holding PMV PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,175,628 | +31.2% | 187,800 | 0.0% | 0.18% | +22.7% |
| Q1 2023 | $895,806 | -45.2% | 187,800 | 0.0% | 0.15% | -57.3% |
| Q4 2022 | $1,633,860 | -26.9% | 187,800 | 0.0% | 0.35% | +13.2% |
| Q3 2022 | $2,235,000 | -16.5% | 187,800 | 0.0% | 0.31% | +8.4% |
| Q2 2022 | $2,676,000 | -39.2% | 187,800 | -1.4% | 0.29% | -40.9% |
| Q4 2021 | $4,401,000 | -22.5% | 190,525 | 0.0% | 0.48% | +1.5% |
| Q3 2021 | $5,678,000 | +97.7% | 190,525 | +126.6% | 0.48% | +145.9% |
| Q2 2021 | $2,872,000 | +101.4% | 84,074 | +93.9% | 0.19% | +78.0% |
| Q1 2021 | $1,426,000 | – | 43,356 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 4,179,416 | $257,076,000 | 54.42% |
| INTERWEST VENTURE MANAGEMENT CO | 6,469,911 | $397,964,000 | 49.71% |
| Octagon Capital Advisors LP | 250,000 | $15,378,000 | 5.33% |
| Boxer Capital, LLC | 2,268,236 | $139,519,000 | 4.48% |
| COMMODORE CAPITAL LP | 125,000 | $7,689,000 | 4.18% |
| Orbimed Advisors | 7,330,423 | $450,894,000 | 3.95% |
| Asymmetry Capital Management, L.P. | 96,595 | $5,942,000 | 2.71% |
| Avoro Capital Advisors LLC | 2,350,267 | $130,536,000 | 2.25% |
| RA Capital Management | 1,710,265 | $105,198,000 | 1.47% |
| HighVista Strategies LLC | 22,654 | $1,393,000 | 0.89% |